News
If your current reaction to recent market volatility is to expect it to continue indefinitely, you will likely be ...
Sandstorm Gold Ltd. offers a compelling long-term growth opportunity, with a diversified portfolio and a robust deal pipeline ...
PNKP TechnologyShown in Past Study to Increase Survival Rate in Colorectal Cancer Bearing Mice VANCOUVER, BC / ACCESS Newswire / April 17, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frank ...
To help with the search, I reached out to Joel Fleming from Yarra Capital Management and Shaun Weick from Wilson ... currently conducting a Phase 3 clinical trial for a treatment targeting focal ...
13d
MarketBeat on MSNJohnson & Johnson Earnings Transcript (NYSE:JNJ)Presentation Operator Good morning, and welcome to Johnson Johnson's First Quarter 2025 Earnings Conference Call. [Operator ...
Introduction There is now emerging evidence to suggest a longitudinal association between specific neurodevelopmental conditions (NDCs) in childhood or adolescence (ie, autism, attention deficit ...
Salmon is a great source of an antioxidant called astaxanthin, which is known to boost the immune system and protect against neurodegenerative ... A systematic review and meta-analysis of randomized ...
April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system ... seamless bidirectional data flow to sponsors to reduce manual ...
Lurie Children's Hospital of Chicago. "In our experience, we have found that systems like Veeva SiteVault with a CTMS provide a streamlined user experience. This can help drive speed for the ...
Veeva Systems recently announced the launch of Veeva SiteVault CTMS, aiming to enhance clinical trial management efficiency, which coincides with a notable 10% share price increase over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results